These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 22038204)

  • 1. Increased urinary calcium excretion caused by ceftriaxone: possible association with urolithiasis.
    Kimata T; Kaneko K; Takahashi M; Hirabayashi M; Shimo T; Kino M
    Pediatr Nephrol; 2012 Apr; 27(4):605-9. PubMed ID: 22038204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal urinary calcium/creatinine ratios in African-American and Caucasian children.
    So NP; Osorio AV; Simon SD; Alon US
    Pediatr Nephrol; 2001 Feb; 16(2):133-9. PubMed ID: 11261680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceftriaxone-associated Biliary Pseudolithiasis with Elderly Type 1 Diabetes Mellitus: Two Case Reports.
    Kanazawa K; Suzuki S; Inaba T; Koga S; Kuwabara K
    Intern Med; 2023 Nov; 62(22):3367-3371. PubMed ID: 37032086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a potential clinical interaction between ceftriaxone and calcium.
    Steadman E; Raisch DW; Bennett CL; Esterly JS; Becker T; Postelnick M; McKoy JM; Trifilio S; Yarnold PR; Scheetz MH
    Antimicrob Agents Chemother; 2010 Apr; 54(4):1534-40. PubMed ID: 20086152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymptomatic ceftriaxone-associated pseudolithiasis.
    Sasaki O; Sugimura K; Shinoda M; Shinkai M
    J Gen Fam Med; 2019 Sep; 20(5):209-212. PubMed ID: 31516810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceftriaxone-associated pseudolithiasis.
    Kurihara M; Tokuda Y
    J Gen Fam Med; 2021 Sep; 22(5):293. PubMed ID: 34484998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceftriaxone Administration Associated with Lithiasis in Children: Guilty or Not? A Systematic Review.
    Louta A; Kanellopoulou A; Alexopoulou Prounia L; Filippas M; Tsami FF; Vlachodimitropoulos A; Vezakis A; Polydorou A; Georgopoulos I; Gkentzi D; Spyridakis I; Karatza A; Sinopidis X
    J Pers Med; 2023 Apr; 13(4):. PubMed ID: 37109057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefazolin sodium pentahydrate cause urolithiasis: a case report and literature review.
    Wang F; Nie W; Wang Z; Tian S; Dong J
    J Surg Case Rep; 2022 Apr; 2022(4):rjac115. PubMed ID: 35422990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-Lactams Toxicity in the Intensive Care Unit: An Underestimated Collateral Damage?
    Roger C; Louart B
    Microorganisms; 2021 Jul; 9(7):. PubMed ID: 34361942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Application of External Ureteral Catheters in Children With Acute Kidney Injury Caused by Ceftriaxone-Induced Urolithiasis.
    Lin H; Geng H; Xu G; Fang X; He L; Xu M
    Front Pediatr; 2020; 8():200. PubMed ID: 32391297
    [No Abstract]   [Full Text] [Related]  

  • 11. Ceftazidime-related urinary calculi in a young boy: a case report.
    Gao P; Liu Z; Yang H; He Z; Zhang Z; Guo X; Zhang H; Ai W; Du D
    J Int Med Res; 2020 Apr; 48(4):300060520921667. PubMed ID: 32351152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computed tomography findings of ceftriaxone-associated biliary pseudocholelithiasis in adults.
    Yoshida R; Yoshizako T; Katsube T; Kitagaki H
    Jpn J Radiol; 2019 Dec; 37(12):826-831. PubMed ID: 31654330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-Induced Urolithiasis in Pediatric Patients.
    Sighinolfi MC; Eissa A; Bevilacqua L; Zoeir A; Ciarlariello S; Morini E; Puliatti S; Durante V; Ceccarelli PL; Micali S; Bianchi G; Rocco B
    Paediatr Drugs; 2019 Oct; 21(5):323-344. PubMed ID: 31541411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of hypercalciuria in patients receiving intravenous Cefotaxime.
    Kalantari Z; Yousefichaijan P; Kahbazi M; Shabestari AA
    J Family Med Prim Care; 2019 May; 8(5):1558-1561. PubMed ID: 31198713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypercalciuria following ceftriaxone a fact or myth.
    Azarfar A; Esmaeeli M; Ravanshad Y; Bagheri S; Khodashenas E; Ghane-Sharbaf F; Malaki M; Mohamadian AH
    J Renal Inj Prev; 2015; 4(3):101-3. PubMed ID: 26468483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etiologic and epidemiologic pattern of urolithiasis in north iran;review of 10-year findings.
    Mohammadjafari H; Barzin M; Salehifar E; Khademi Kord M; Aalaee A; Mohammadjafari R
    Iran J Pediatr; 2014 Feb; 24(1):69-74. PubMed ID: 25793048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute kidney injury caused by ceftriaxone-induced urolithiasis in children: a single-institutional experience in diagnosis, treatment and follow-up.
    Shen X; Liu W; Fang X; Jia J; Lin H; Xu M; Geng H
    Int Urol Nephrol; 2014 Oct; 46(10):1909-14. PubMed ID: 24879561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing urinary calcium excretion after ceftriaxone and cephalothin therapy in adults: possible association with urolithiasis.
    Otunctemur A; Ozbek E; Polat EC; Cekmen M; Dursun M; Cakir SS
    Urolithiasis; 2014 Apr; 42(2):105-8. PubMed ID: 24310104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anuria and abdominal pain induced by ceftriaxone-associated ureterolithiasis in adults.
    Li ZL; Li HL; Chen HW; Li HC; Zhang P; Wang ZM; Chong T
    Int Urol Nephrol; 2013 Feb; 45(1):73-6. PubMed ID: 23180444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outpatient parenteral antimicrobial therapy with ceftriaxone, a review.
    Duncan CJ; Barr DA; Seaton RA
    Int J Clin Pharm; 2012 Jun; 34(3):410-7. PubMed ID: 22527482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.